Deerfield Management Company, L.P. (Series C) Imara Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.78 - $9.04 $538,772 - $718,363	-79,465 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.18 - $23.98 $4.08 Million - $12 Million	-498,403 Reduced 86.25%	79,465 $671,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $951,999 - $1.75 Million	60,215 Added 11.63%	577,868 $12.7 Million
Q3 2020 Nov 16, 2020	BUY	$18.75 - $28.58 $1.76 Million - $2.68 Million	93,653 Added 22.09%	517,653 $10.5 Million
Q2 2020 Aug 14, 2020	SELL	$15.6 - $54.87 $1.19 Million - $4.17 Million	-76,000 Reduced 15.2%	424,000 $11.7 Million
Q1 2020 May 15, 2020	BUY	$15.0 - $16.6 $7.5 Million - $8.3 Million	500,000 New	500,000 $8.02 Million

Others Institutions Holding IMRA

# of Institutions

Shares Held

104K

Call Options Held

Put Options Held

170K

Jefferies Group LLC New York, NY

104K
Shares

$2.19 Million
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About IMARA Inc.

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

More about IMRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account